Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 3
2010 6
2011 7
2012 9
2013 6
2014 11
2015 14
2016 14
2017 13
2018 13
2019 15
2020 15
2021 15
2022 17
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment.
Plotti F, Terranova C, Luvero D, Bartolone M, Messina G, Feole L, Cianci S, Scaletta G, Marchetti C, Di Donato V, Fagotti A, Scambia G, Benedetti Panici P, Angioli R. Plotti F, et al. Among authors: marchetti c. Chemotherapy. 2020;65(3-4):77-84. doi: 10.1159/000510839. Epub 2020 Nov 16. Chemotherapy. 2020. PMID: 33197913 Free article. Review.
Bartholin gland cancer.
Di Donato V, Casorelli A, Bardhi E, Vena F, Marchetti C, Muzii L, Benedetti Panici P. Di Donato V, et al. Among authors: marchetti c. Crit Rev Oncol Hematol. 2017 Sep;117:1-11. doi: 10.1016/j.critrevonc.2017.06.005. Epub 2017 Jun 13. Crit Rev Oncol Hematol. 2017. PMID: 28807231 Review.
Management of Endometriomas.
Muzii L, Di Tucci C, Di Feliciantonio M, Galati G, Verrelli L, Donato VD, Marchetti C, Panici PB. Muzii L, et al. Among authors: marchetti c. Semin Reprod Med. 2017 Jan;35(1):25-30. doi: 10.1055/s-0036-1597126. Epub 2016 Dec 7. Semin Reprod Med. 2017. PMID: 27926971 Review.
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.
Nebgen DR, Domchek SM, Kotsopoulos J, de Hullu JA, Crosbie EJ, Paramanandam VS, Brood-van Zanten MMA, Norquist BM, Guise T, Rozenberg S, Kurian AW, Pederson HJ, Yuksel N, Michaelson-Cohen R, Bober SL, da Silva Filho AL, Johansen N, Guidozzi F, Evans DG, Menon U, Kingsberg SA, Powell CB, Grandi G, Marchetti C, Jacobson M, Brennan DJ, Hickey M. Nebgen DR, et al. Among authors: marchetti c. BJOG. 2023 Nov;130(12):1437-1450. doi: 10.1111/1471-0528.17511. Epub 2023 May 2. BJOG. 2023. PMID: 37132126 Review.
Immune check-point in endometrial cancer.
De Felice F, Marchetti C, Tombolini V, Panici PB. De Felice F, et al. Among authors: marchetti c. Int J Clin Oncol. 2019 Aug;24(8):910-916. doi: 10.1007/s10147-019-01437-7. Epub 2019 May 2. Int J Clin Oncol. 2019. PMID: 31049759 Review.
Fertility preservation in gynaecologic cancers.
De Felice F, Marchetti C, Di Pinto A, Musella A, Palaia I, Porpora MG, Muzii L, Tombolini V, Panici PB, Tomao F. De Felice F, et al. Among authors: marchetti c. Ecancermedicalscience. 2018 Jan 16;12:798. doi: 10.3332/ecancer.2018.798. eCollection 2018. Ecancermedicalscience. 2018. PMID: 29434664 Free PMC article. Review.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: marchetti c. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
Incorvaia L, Perez A, Marchetti C, Brando C, Gristina V, Cancelliere D, Pivetti A, Contino S, Di Giovanni E, Barraco N, Bono M, Giurintano A, Bazan Russo TD, Gottardo A, Cutaia S, Pedone E, Peri M, Corsini LR, Fanale D, Galvano A, Scambia G, Badalamenti G, Russo A, Bazan V. Incorvaia L, et al. Among authors: marchetti c. Cancer Treat Rev. 2023 Dec;121:102650. doi: 10.1016/j.ctrv.2023.102650. Epub 2023 Oct 31. Cancer Treat Rev. 2023. PMID: 37939446 Free article. Review.
Pembrolizumab for advanced cervical cancer: safety and efficacy.
De Felice F, Giudice E, Bolomini G, Distefano MG, Scambia G, Fagotti A, Marchetti C. De Felice F, et al. Among authors: marchetti c. Expert Rev Anticancer Ther. 2021 Feb;21(2):221-228. doi: 10.1080/14737140.2021.1850279. Epub 2020 Nov 26. Expert Rev Anticancer Ther. 2021. PMID: 33183120 Review.
157 results